(2006). Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro.
(2007). Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation.
(1988). Novel regulators of bone formation: molecular clones and activities.
(1999). Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect.
(2003). Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat.
(2006). Osteogenic protein-1 (BMP-7) accelerates healing of scaphoid non-union with proximal pole sclerosis.
(2001). Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions.
(2009). Overexpression of BMP3 in the developing skeleton alters endochondral bone formation resulting in spontaneous rib fractures.
Paralkar VM (2007) BMP-6 exerts its osteoinductive effect through activation of IGF-I and EGF pathways.
(2011). Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study. Pharmacoepidemiol Drug Saf
(2002). Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients.
(2005). Regulation of BMP-induced ectopic bone formation by Ahsg.
(2007). RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation.
(2009). Role of bone morphogenetic proteins and their antagonists in healing of bone fracture.
(2010). Sequential BMP-2/BMP-7 delivery from polyester nanocapsules.
(1999). Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.
(2009). Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application.
(1999). Stimulation of bone formation in vitro and in rodents by statins.
(2009). Targeting bone morphogenetic protein antagonists: in vitro and in vivo evidence of their role in bone metabolism. Expert Opin Ther Targets 13:123–137
(2001). TGFbeta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation.
(1997). The Bmp8 gene is expressed in developing skeletal tissue and maps near the Achondroplasia locus on mouse chromosome 4.
(1998). The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes.
(2010). The control of fracture healing and its therapeutic targeting: improving upon nature.
(2007). The health economics of the treatment of long-bone non-unions.
(1992). The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily.
(2009). The origin of bmp16, a novel Bmp2/4 relative, retained in teleost fish genomes.
(2006). The role of inhibitory molecules in fracture healing.
(2003). The roles of bone morphogenetic protein (BMP) 12 in stimulating the proliferation and matrix production of human patellar tendon fibroblasts.
(1993). Thesleff I
(2000). Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent.
V alentin-Opran A et al (2006) Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial.